{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:14:07Z","timestamp":1781273647478,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Pituitary neuroendocrine tumors (pitNETs) are benign tumors that may recur after surgical resection or persist following medical management. The objective of this study was to evaluate outcomes and toxicities of patients with pitNETs treated with stereotactic radiosurgery (SRS) at a single institution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We completed a retrospective, single-institution study of patients with pitNETs treated with frame-based, single-fraction, cobalt-60 SRS between September 2005 and June 2023. The primary endpoint was local tumor control. Secondary endpoints included endocrine control (for functional tumors), overall survival, and toxicities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 88 lesions in 83 patients were treated with SRS. Most lesions (70%) were non-functional tumors. Of the 26 functioning tumors, 6 patients achieved endocrine remission with SRS alone (23%), and the remainder achieved remission with combined medical management. With a median patient follow-up of 4.7 years, no local tumor recurrences were observed with an estimated local control probability of 100%. Two- and five-year overall survival estimates were 97% (95% confidence interval [CI] 89\u201399) and 95% (95% CI 84\u201398), respectively. Causes of death were unrelated to PitNET or SRS. Twelve patients (14%) developed hypopituitarism after SRS. Despite the 34 lesions that were \u2264\u20093\u00a0mm from optic structures, no patients developed any optic neuropathy or visual decline post SRS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SRS is a highly effective modality for recurrent or residual pitNETs. This study observed a local control of 100% with no cases of optic toxicities after a median follow-up of 4.7 years. These observed findings suggest that dose de-escalation may be possible for future treatment of pitNETs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11060-024-04864-3","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T10:16:42Z","timestamp":1730110602000},"page":"423-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pituitary neuroendocrine tumors treated with stereotactic radiosurgery"],"prefix":"10.1007","volume":"171","author":[{"given":"Inhwa","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Sourour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristotelis","family":"Kalyvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Keilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Cusimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normand","family":"Laperriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira B.","family":"Alli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek S.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"6","key":"4864_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB et al (2022) Clinical biology of the pituitary adenoma. Endocr Rev 43(6):1003\u20131037. https:\/\/doi.org\/10.1210\/endrev\/bnac010","journal-title":"Endocr Rev"},{"issue":"16","key":"4864_CR2","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jama.2023.5444","volume":"329","author":"NA Tritos","year":"2023","unstructured":"Tritos NA, Miller KK (2023) Diagnosis and management of pituitary adenomas: a review. JAMA 329(16):1386. https:\/\/doi.org\/10.1001\/jama.2023.5444","journal-title":"JAMA"},{"issue":"3","key":"4864_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11060-018-2925-2","volume":"139","author":"CC Shen","year":"2018","unstructured":"Shen CC, You WC, Sun MH et al (2018) Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery. J Neurooncol 139(3):767\u2013775. https:\/\/doi.org\/10.1007\/s11060-018-2925-2","journal-title":"J Neurooncol"},{"issue":"19","key":"4864_CR4","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.3390\/cancers13194998","volume":"13","author":"L Albano","year":"2021","unstructured":"Albano L, Losa M, Barzaghi LR et al (2021) Gamma knife radiosurgery for pituitary tumors: a systematic review and meta-analysis. Cancers 13(19):4998. https:\/\/doi.org\/10.3390\/cancers13194998","journal-title":"Cancers"},{"issue":"2","key":"4864_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11060-018-2801-0","volume":"138","author":"N Forster","year":"2018","unstructured":"Forster N, Warnick R, Takiar V, Pater L, Breneman J (2018) Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery. J Neurooncol 138(2):335\u2013340. https:\/\/doi.org\/10.1007\/s11060-018-2801-0","journal-title":"J Neurooncol"},{"issue":"1","key":"4864_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijrobp.2018.01.053","volume":"110","author":"MT Milano","year":"2021","unstructured":"Milano MT, Grimm J, Soltys SG et al (2021) Single- and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways. Int J Radiat Oncol 110(1):87\u201399. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.053","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"4864_CR7","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol 76(3):S10\u2013S19. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1754","journal-title":"Int J Radiat Oncol"},{"key":"4864_CR8","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Published online 2017."},{"issue":"3","key":"4864_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/neuonc\/noz225","volume":"22","author":"R Kotecha","year":"2020","unstructured":"Kotecha R, Sahgal A, Rubens M et al (2020) Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion. Neuro-Oncol 22(3):318\u2013332. https:\/\/doi.org\/10.1093\/neuonc\/noz225","journal-title":"Neuro-Oncol"},{"issue":"2","key":"4864_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3171\/2013.3.JNS12766","volume":"119","author":"JP Sheehan","year":"2013","unstructured":"Sheehan JP, Starke RM, Mathieu D et al (2013) Gamma knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study: clinical article. J Neurosurg 119(2):446\u2013456. https:\/\/doi.org\/10.3171\/2013.3.JNS12766","journal-title":"J Neurosurg"},{"issue":"3","key":"4864_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijrobp.2013.06.2047","volume":"87","author":"JA Leavitt","year":"2013","unstructured":"Leavitt JA, Stafford SL, Link MJ, Pollock BE (2013) Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol 87(3):524\u2013527. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.06.2047","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"4864_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-8140(96)91807-1","volume":"41","author":"RW Tsang","year":"1996","unstructured":"Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ (1996) Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol 41(1):45\u201353. https:\/\/doi.org\/10.1016\/S0167-8140(96)91807-1","journal-title":"Radiother Oncol"},{"key":"4864_CR13","unstructured":"Statistics Canada (2023) (table). Census Profile. 2021 Census of Population. Statistics Canada Catalogue no. 98-316-X2021001. Ottawa. Released November 15, 2023. https:\/\/www12.statcan.gc.ca\/census-recensement\/2021\/dp-pd\/prof\/index.cfm?Lang=E (accessed August 2, 2024)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04864-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:07:40Z","timestamp":1735862860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04864-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4864"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04864-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}